TSS
HUMA icon

Two Sigma Securities’s Humacyte HUMA Stock Holding History

Two Sigma Securities’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.74K Buy
+12,759
New +$13.3K ﹤0.01% 1490
2025
Q4 		– Sell
-14,891
Closed -$25.9K – 1712
2025
Q3 		$25.9K Buy
+14,891
New +$29.2K ﹤0.01% 1088

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AP
Antipodes Partners Royal Exchange, Australia $5.19B AUM 36.17% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Two Sigma Securities's HUMA Position: Q1 2026 in Review

Two Sigma Securities opened a new position in Humacyte (HUMA) in Q1 2026: 12,759 shares worth $7.74K. The stake represents ﹤0.01% of the portfolio and ranks #1490 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in HUMA as recently as Q3 2025.

Two Sigma Securities first reported a position in HUMA in Q3 2025 and has held it in 2 quarters since. The position peaked at $25.9K in Q3 2025. 158 funds tracked by Wall St. Rank hold HUMA as of Q1 2026.

  • Two Sigma Securities held 12,759 shares of Humacyte worth $7.74K as of Q1 2026.
  • Humacyte was a new Two Sigma Securities position in Q1 2026.
  • Humacyte made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1490 holding.
  • Two Sigma Securities first reported a position in Humacyte in Q3 2025 and has held it in 2 quarters since.
  • Two Sigma Securities's Humacyte position peaked at $25.9K in Q3 2025.
  • 158 funds tracked by Wall St. Rank held Humacyte as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.